Jennifer R Diamond

Jennifer R Diamond

UNVERIFIED PROFILE

Are you Jennifer R Diamond?   Register this Author

Register author
Jennifer R Diamond

Jennifer R Diamond

Publications by authors named "Jennifer R Diamond"

Are you Jennifer R Diamond?   Register this Author

32Publications

953Reads

31Profile Views

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.

N Engl J Med 2019 02;380(8):741-751

From the Massachusetts General Hospital Cancer Center (A.B., S.J.I.) and Dana-Farber Cancer Institute (S.M.T.), Harvard Medical School, Boston; Vanderbilt-Ingram Cancer Center, Nashville (I.A.M., V.G.A.); Weill Cornell Medical College (L.T.V.) and New York-Presbyterian-Columbia University Irving Medical Center (K.K.), New York; University of Colorado Cancer Center, Aurora (J.R.D.); Texas Oncology, Baylor University Medical Center, US Oncology, Dallas (J.O.); Orlando Health University of Florida Health Cancer Center, Orlando (R.L.M., N.C.S.); Yale University School of Medicine, New Haven, CT (A.D.S.); University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.); Immunomedics, Morris Plains, NJ (D.M.G., R.I., S.W., R.M.S., W.A.W.); and AIS Consulting, Ann Arbor, MI (A.M.S.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1814213
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1814213DOI Listing
February 2019

Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer.

Oncology (Williston Park) 2018 Oct;32(10):513-5

View Article

Download full-text PDF

Source
October 2018

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.

J Clin Oncol 2017 Jul 14;35(19):2141-2148. Epub 2017 Mar 14.

Aditya Bardia, Steven J. Isakoff, and Dejan Juric, Massachusetts General Hospital Cancer Center; Aditya Bardia, Steven J. Isakoff, Dejan Juric, and Sara M. Tolaney, Harvard Medical School; Sara M. Tolaney, Dana-Farber Cancer Institute, Boston, MA; Ingrid A. Mayer, Vandana Abramson, and Jordan Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN; Jennifer R. Diamond and Wells A. Messersmith, University of Colorado Cancer Center, Aurora, CO; Rebecca L. Moroose and Nikita C. Shah, University of Florida Health Cancer Center, Orlando, FL; Alexander N. Starodub, Indiana University Health Center for Cancer Care, Goshen, IN; Joyce O'Shaughnessy, Texas Oncology-Baylor Charles A. Sammons Cancer Center; Joyce O'Shaughnessy, US Oncology, Dallas, TX; Kevin Kalinsky, Columbia University Herbert Irving Comprehensive Cancer Center; Allyson J. Ocean and Linda T. Vahdat, Weill Cornell Medicine, New York, NY; Michael Guarino, Helen F. Graham Cancer Center, Newark, DE; William A. Wegener, Pius Maliakal, Robert M. Sharkey, Serengulam V. Govindan, and David M. Goldenberg, Immunomedics, Morris Plains, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.8297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559902PMC
July 2017

Triple-negative breast cancer: bridging the gap from cancer genomics to predictive biomarkers.

Ther Adv Med Oncol 2014 May;6(3):88-100

Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Mailstop 8117, 12801 East 17th Avenue, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834013519843DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987651PMC
May 2014

From bench to bedside: lessons learned in translating preclinical studies in cancer drug development.

J Natl Cancer Inst 2013 Oct 19;105(19):1441-56. Epub 2013 Sep 19.

Affiliation of authors: Division of Medical Oncology, University of Colorado, Aurora, CO (CHL, A-CT, SL, JRD, SGE).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787906PMC
October 2013

BRCA in breast cancer: from risk assessment to therapeutic prediction.

Drug News Perspect 2009 Dec;22(10):603-8

Division of Medical Oncology, Department of Medicine, University of Colorado Cancer Center, University of Colorado at Denver Anschutz Medical Campus, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1358/dnp.2009.22.10.1440985DOI Listing
December 2009

Early-stage BRCA2-linked breast cancer diagnosed in the first trimester of pregnancy associated with a hypercoagulable state.

Oncology (Williston Park) 2009 Aug;23(9):784-91

Division of Medical Oncology, University of Colorado Health Sciences Center, Denver, Colorado, USA.

View Article

Download full-text PDF

Source
August 2009

Hepatic complications of breast cancer.

Lancet Oncol 2009 Jun;10(6):615-21

Division of Medical Oncology, Department of Medicine, University of Colorado Cancer Center, University of Colorado at Denver Anschutz Medical Campus, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(09)70029-4DOI Listing
June 2009